Our Research

The following funding opportunities reflect ITOG’s commitment to advancing innovative thyroid cancer research across the translational, clinical, and collaborative spectrum. Together, these programs are designed to catalyze scientific discovery, support investigator-driven initiatives, and accelerate the development of improved therapeutic strategies through multidisciplinary collaboration and rigorous peer review. Download our current funding opportunities to learn more about available research support and application details.

Robert F. Gagel Discovery Award

Supporting innovative research that bridges laboratory discoveries and clinical applications to advance new and improved treatments for thyroid cancer.

Dream Team Science Award

This award supports collaborative, multidisciplinary research that brings together diverse expertise to address critical challenges and improve outcomes in thyroid cancer.

ITOG Sponsored Clinical Trial Funding

This funding pathway supports ITOG clinical trials by advancing smaller studies, pilot initiatives, and targeted research aligned with key scientific priorities.

ITOG Registries

These registries collect and unify global clinical and research data to generate insights, identify patterns, and advance understanding of rare and complex thyroid cancers.

Learn About Active ITOG Sponsored Clinical Trials

ITOG advances thyroid cancer care by designing and supporting collaborative, multicenter clinical research accessible to physicians, researchers, and patients worldwide.